Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Westlake Chemical Partners (WLKP) Total Debt (2016 - 2025)

Historic Total Debt for Westlake Chemical Partners (WLKP) over the last 13 years, with Q3 2025 value amounting to $399.7 million.

  • Westlake Chemical Partners' Total Debt changed 0.0% to $399.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $399.7 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $399.7 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Westlake Chemical Partners reported Total Debt of $399.7 million as of Q3 2025, which was down 0.0% from $399.7 million recorded in Q2 2025.
  • Westlake Chemical Partners' Total Debt's 5-year high stood at $399.7 million during Q1 2021, with a 5-year trough of $22.6 million in Q1 2022.
  • For the 5-year period, Westlake Chemical Partners' Total Debt averaged around $379.8 million, with its median value being $399.7 million (2021).
  • As far as peak fluctuations go, Westlake Chemical Partners' Total Debt tumbled by 9434.06% in 2022, and later surged by 166698.35% in 2023.
  • Westlake Chemical Partners' Total Debt (Quarter) stood at $399.7 million in 2021, then changed by 0.0% to $399.7 million in 2022, then changed by 0.0% to $399.7 million in 2023, then changed by 0.0% to $399.7 million in 2024, then changed by 0.0% to $399.7 million in 2025.
  • Its Total Debt was $399.7 million in Q3 2025, compared to $399.7 million in Q2 2025 and $399.7 million in Q1 2025.